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Abstract. The sequential appearance of the extracellu- 
lar matrix (ECM) protein, cytotactin, was examined 
during development of the chicken embryo by immu- 
nohistochemical techniques. Although cytotactin was 
identified as a molecule that mediates glia-neuron in- 
teractions, preliminary immunohistochemical local- 
ization of the molecule suggested that it was an ECM 
protein with a widespread but nonetheless more re- 
stricted distribution than either fibronectin or lami- 
nin. In the present study, it was found that cytotactin 
is first present in the gastrulating chicken embryo. It 
appears later in the basement membrane of the devel- 
oping neural tube and notochord in a temporal se- 
quence beginning in the cephalic regions and proceed- 
ing caudally. Between 2 and 3 d of development, the 
molecule is present at high levels in the early neural 
crest pathways (surrounding the neural tube and som- 
ires) but, in contrast to fibronectin and laminin, is not 
found in the lateral plate mesoderm or ectoderm. At 
later times, cytotactin is expressed extensively in the 
central nervous system, in lesser amounts in the pe- 
ripheral nervous system, and in a number of non- 
neural sites, most prominently in all smooth muscles 
and in basement membranes of lung and kidney. Cy- 
totactin appears in adult tissues with distributions that 
are similar to those seen in embryonic tissues. The 
findings raise the possibility that certain ECM proteins 
contribute to pattern formation in embryogenesis as a 
result of their restricted expression in a spatiotempor- 
ally regulated fashion at some sites but not at others. 
URING development,  collectives of cells that  have 
different histories move together and influence each 
other, inducing specific cytodifferentiation events as 
a result of  their mutual interaction (3, 33, 40). Such embryonic 
induction  results in morphogenetic patterning  in the  early 
embryo as well as in the development of  more complex tissues 
and organs. Morphoregulation, or the establishment of pat- 
tern, is therefore highly dependent upon both the interactions 
among groups of ceils and their subsequent movement. It has 
been proposed that the coordinate spatiotemporal expression 
at cell surfaces of cell adhesion molecules (CAMs)  ~  and sub- 
strate adhesion molecules (SAMs) provides a means of regu- 
lation of these processes (10-13). This proposal implies that 
CAMs and SAMs appear  in defined sites at characteristic 
times during development. 
A number of CAMs have been identified (2, 7, 16, 17, 22- 
24,  29,  31), each of which appears in a  distinct sequence 
during embryogenesis and histogenesis. N-CAM, the neural 
cell adhesion molecule (23), and L-CAM, the liver cell adhe- 
sion molecule (16), are both present in the chicken blastoderm 
(15) and  undergo  dramatic  redistributions  at the  time of 
primary neural induction (15, 41, 42). These two CAMs are 
present in very early embryos, are both expressed on deriva- 
1. Abbreviations used in this paper: CAM, cell adhesion molecule; CNS, central 
nervous  system;  N-CAM, neural CAM; L-CAM, liver CAM; Ng-CAM, neuron- 
glia CAM; PJNaC1, phosphate-buffered  saline; PNS, peripheral nervous  system; 
SAM, substrate adhesion molecule; ECM, extracellular matrix. 
fives of all three germ layers during development, and are 
therefore designated primary CAMs. In contrast, the neuron- 
glia cell adhesion molecule (Ng-CAM), which is involved in 
neuron-glia (17) and neuron-neuron 08) adhesion in vitro, 
appears later in development on neuroectodermal derivatives 
only (8, 43); it is designated a secondary CAM. The distribu- 
tions of each of these CAMs have been correlated with major 
morphological events during embryogenesis (6, 7, 15, 22, 25, 
31, 39, 41) and histogenesis (4-6,  8,  14, 29, 32, 35-38, 42, 
43), and their expression occurs in restricted but contiguous 
regions in a classical fate map (48) of the avian blastoderm 
(12, 13, 43). 
The existence of such distributions implies developmental 
regulation  of the  expression of these  molecules. A  major 
means of regulation of cell adhesion occurs through modula- 
tion of CAMs at the cell surface by alterations in the amount 
or prevalence, distribution, or chemistry of these cell surface 
proteins  (9). A striking example of modulation related to 
morphogenesis is seen as  N-CAM-containing  neural  crest 
cells begin to migrate. These cells lose N-CAM and migrate 
through fibronectin-rich regions, then reexpress N-CAM at 
sites at which they will differentiate (44). Thus coordinate 
expression of  both a CAM (N-CAM) and a SAM (fibronectin) 
is correlated first with movement and later with differentiation 
events. The modulation of CAM expression, the restricted 
CAM  distributions  within  the  fate  map,  and  the  known 
function of CAMs all strongly implicate these molecules as 
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must be correlated with that of SAMs during particular mor- 
phogenetic events. 
These observations indicate that the temporal and spatial 
expression of certain surface molecules follows a sequence in 
development; at  any time,  this  sequence is  seen  at  some 
regions of  the embryo and not at others, i.e., it is site-restricted. 
It is of particular importance to determine whether certain 
SAMs, like CAMs, appear in definite sequences that are site- 
restricted. We have  recently identified and  isolated a  new 
extracellular matrix  (ECM)  molecule, cytotactin (20),  and 
have shown that it is involved in glia-neuron adhesion. Cy- 
totactin was initially isolated as one of  the proteins that carried 
a carbohydrate determinant recognized by monoclonal anti- 
body NC- l (20). NC- l is a monoclonal antibody raised against 
quail  ciliary ganglia  that  also  recognizes determinants ex- 
pressed on migrating neural crest cells (47) as well as N-CAM 
and Ng-CAM (l 9). Cytotactin appears as three closely related 
polypeptides of Mr 220,000, 200,000, and  190,000  on SDS 
polyacrylamide gels under reducing conditions; under non- 
reducing conditions it barely enters a 6% gel, which suggests 
that the native polypeptides form polymers that are disulfide 
cross-linked. The molecule is synthesized by gila as well as by 
cells isolated from kidney, lung, and smooth muscle. It was 
not seen in striated or cardiac muscle and appeared to be less 
widespread than the ubiquitous ECM molecules fibronectin 
and laminin. These findings raised the possibility that cyto- 
tactin might, like the CAMs, be restricted to certain specific 
regions in a classical fate map. 
With this in mind, we have now examined the appearance 
of cytotactin during embryogenesis and have compared its 
localization with that of flbronectin and laminin. In addition, 
we have assessed whether the expression of this molecule is 
correlated with paths of cell migration or with other salient 
morphogenetic features, implying various related functions in 
different tissues. The results of this study indicate that cyto- 
tactin is a matrix protein with a sharply restricted pattern of 
expression. They raise the possibility that cytotactin and other 
such proteins may help to guide morphogenetic movements 
and subsequent developmental pattern formation by provid- 
ing a temporally and spatially modulated extracellular envi- 
ronment for interacting groups of cells. 
Materials and Methods 
Preparation of Tissues 
White Leghorn chicken embryos were  staged according to  the number of 
somites  or according to Hamburger and Hamilton (2 l) for later stages. Embryos 
were fixed in 2.5% paraformaldehyde/0.02% glutaraldehyde in 100 mM phos- 
phate buffer (pH 7.2) (P~) at room temperature for 10-60 min depending on 
the age of the embryo. After quenching with 0.1  M  glycine in phosphate- 
buffered saline (P.dNaCI), the embryos were infiltrated with 30% sucrose in Pi/ 
NaCI at 4"(:7. Very early embryos were first embedded in 1% low-melting-point 
agarose (Bethesda Research Laboratories, Bohesda, MD) in  18% sucrnsc/Pd 
NaCl to facilitate  handling and orientation. The embryos were mounted in 
OCT compound (Lab-Tek, Naperville,  IL) on dry ice; 10-urn cryostat sections 
(IEC CTF microtome-cryostat) were attached to poly(L-lysine)-coated  slides. 
Immunofluorescence 
Indirect immunofluorescent  labeling was done as described (6). Affinity-puri- 
fied anti-laminin antibodies were purchased from E. Y. Laboratories, Inc. (San 
Mateo, CA) and anti-fibronectin antibodies were prepared as previously de- 
scribed (30).  Preparation of rabbit anti-cytotactin routinely used in staining 
experiments is described below. Slides were mounted in 90% glycerol/PdNaCl/ 
0.1% p-phenylenediamine to prevent bleaching.  Sections were  photographed 
on Tri-X film with a  Nikon UFX camera on a  Zeiss Universal microscope 
equipped with IIlRS epifluoresccnee optics. 
Preparation of  ,4ntibodies to Cytotactin 
Cytotactin was purified (20) by immunoaffinity  chromatography using mono- 
clonal antibody HNK-I  (an antibody with similar specificity  to NC-I  [46]) 
immobilized on Sepharose CL-2B, followed by ion exchange chromatography 
on DEAE-celhilose.  This material was used to immunize rabbits; the antibodies 
thus generated showed identical reactivity on Western blots and on frozen 
sections to the anti-cytotactin antibodies prepared and absorbed as previously 
described (20). With the exception of Fig. 8//, which represents staining with 
monoclonal anti-cytotactin, rabbit antibodies against purified cytotactin were 
used in these studies. 
Moncclonal  antibodies  were  prepared  against  purified  cytotactin  and 
screened by ELISA (4) against the same material; clones that were positive by 
this analysis were then tested for their ability to immunoprecipitate radiolabeled 
cytotactin from the supernatants of cultured glial cells (20). In this study, the 
combined culture supernatants from four positive clones were used to confirm 
the immunohistochemical staining and immunoblotting observed with rabbit 
antibodies. 
Immunoblots 
Tissues were  extracted  by  homogenization using a  Polytron  homogenizer 
(Brinkmann Instruments  Co., Westbury, NY) in 5 vol of 30 mM diethylamine, 
I mM EDTA (pHI 1.5), and shaken for 6 h at 40C. The extracts were centrifuged 
at 10,000 g for l0 rain, dialyzed against H20, and 25-#1 aliquots were subjected 
to  gel  elcctrophoresis (27).  Immunoblots were  done  (45)  using polyclonal 
antibodies to cytotactin as described above. 
Results 
Gastrulation 
To assess the earliest appearance of cytotactin in the avian 
blastoderm, we examined sections from early embryos before 
and at various stages ofgastrulation, with particular attention 
to areas of cell movements and epithelial-mesenchymal in- 
terconversions. Cytotactin first  appears in the avian blasto- 
derm  at  the  time  of gastrulation;  it  is  not  found in  the 
blastoderm of fertile but unincubated eggs. At the head proc- 
ess  stage  of gastrulation  (stage  5),  the  molecule is  present 
throughout the basement membrane (Fig. 1A), separating the 
chordamesoderm (presumptive notochord) from the epithe- 
lium  of the  presumptive neural  plate  (i.e.,  at  sites  where 
gastrulation is complete). Staining is punctate at the level of 
the primitive streak where cells  are ingressing  to form the 
middle layer (Fig.  1  C). This pattern occurs reproducibly and 
may reflect the breakdown of the basement membrane in this 
region. Cytotactin is absent from Hensen's node (Fig.  1, E 
and F) and regions posterior to it (Fig.  1, G and/-/) in a later 
stage embryo (stage 9), which is already expressing cytotactin 
in developing anterior structures (see below).  Thus, the ap- 
pearance of cytotactin is subsequent to the regression of the 
primitive streak toward the posterior regions of the embryo. 
Neurulation and Neural Crest Cell Formation 
Because cytotactin was initially isolated as an NC-1  antigen, 
it was of particular interest to examine its distribution during 
the early formation of the neural tube and later during the 
formation and migration of neural crest cells. The anterior- 
posterior differential expression seen in the gastrulation stage 
embryo (Fig.  1) was repeated during neurnlation (Fig. 2) and 
again during somite formation (Fig. 3, see below). In the stage 
9 embryo, cytotactin is prominent in the basement membrane 
of the neural tube and notochord in the anterior (Fig. 2A) 
The Journal of Cell Biology, Volume 102, 1986  1918 Figure I. Cytotactin expression during gastrulation. At the head process stage (stage 5), cytotactin is found in the basement membrane between 
the neural  plate  (np) and presumptive  notochord (pn) in the anterior  region of the blastoderm  where gastrulation  is complete  (A). More 
posteriorly, it is absent from the basement membrane of the epiblast at the level of the primitive streak (ps) where extensive cell movement is 
still taking place (C). The primitive streak contains a small amount of cytotactin in a punctate distribution  in the ingressing middle layer cells 
(6"). B and D are phase images corresponding  to A and C, respectively. In the posterior region of a later stage embryo (stage 9, 7 somites), 
cytotactin is absent both from Hensen's node (hn) (E) and the primitive streak (ps) (G), where gastrulation is still occurring, although cytotactin 
staining has already become prominent in structures of the anterior regions (see Fig. 2). F and H are phase images that correspond to E and G, 
respectively. Bar, 50 ~tm. 
and trunk (Fig. 2 B) regions; however, it is completely absent 
from the posterior regions (Fig. 2, C  and D) even in regions 
where  the  notochord  is  well  formed  and  neurulation  has 
begun (Fig. 2 C). This pattern persists in the embryo through 
the  third  day of development  (Fig.  2,  E-H).  At this  stage, 
cytotactin  is  expressed  only  surrounding  the  neural  tube, 
notochord, somites, and aorta (Fig. 2 E), a much more limited 
distribution  pattern  than  fibronectin  (Fig.  2F).  In the  tail 
region (Fig. 2, G and H), no cytotactin is present (Fig. 2 G), 
although fibronectin staining (Fig. 2 H) clearly delineates the 
neural tube and notochord. 
To examine further the appearance of cytotactin as somite 
Crossin et al. Site-restricted Expression of  Cytotactin  1919 Figure Z Cytotactin staining at various axial levels of 2-d and 3-d embryos. (.4-/)) Transverse sections of a stage 9 embryo (7 somites) at the 
level of the heart primordium (A), through the somites (B), and in regions posterior to the last formed somite (C and D) were stained with 
affinity-purified rabbit anti-cytotaetin. (E-H) Transverse sections of a stage 18 embryo at levels posterior to the omphalomesenteric vein were 
stained with affinity purified rabbit anti-cytotactin (E and G) or rabbit anti-fibronectin (F and H). Note the restricted pattern of cytotactin 
staining (E and G) as compared with the extensive fibronectin staining in sister sections (F and H). Bar, 100 urn. 
formation  progressed,  we  prepared  sagittal  sections  of  10- 
somite  embryos  and  again  observed  an  anterior-posterior 
differential expression in the somites of the posterior trunk 
region (Fig. 3, A and B). Although staining was prominent in 
the basement membranes of the most mature somites, two to 
three of the  newly formed somites and the pre-somitic seg- 
mental  plate  contained  no  cytotactin  (Fig.  3,  A  and  B), 
indicating  that  its  synthesis follows epithelialization of the 
somite. This is in striking contrast to the expression of fibro- 
nectin (Fig.  3 C) and laminin (Fig.  3D) in the somites: fibro- 
nectin strongly stains basement membranes of somites, seg- 
mental  plate,  ectoderm,  and  endoderm,  whereas  laminin 
strongly stains the basement membrane of the ectoderm but 
stains somitic basement membrane at low levels in a punetate 
pattern. Thus, it appears that during neurulation and somi- 
togenesis, cytotactin staining diminishes in the somatic ecto- 
derm and increases in the basement membranes of the neural 
ectoderm, notochord, and somites beginning anteriorly and 
proceeding caudally. Again,  in  posterior trunk  and  tail  re- 
gions, formation of the neural plate, notochord, and somites 
precedes the appearance of cytotactin. 
Cytotactin is present during the formation of neural crest 
The Journal of Cell Biology, Volume 102, 1986  1920 Figure 3. Comparison of cytotactin,  fibronectin, and laminin distributions  during somitogenesis. Parasagittal sections of a  10-somite embryo 
were stained with affinity-purified rabbit anti-cytotaetin  (A and B), rabbit anti-fibroneetin  (C), or affinity-purified anti-laminin  (D). Arrows in 
A show area of enlargement  in serial sections B, C, and D. A represents the entire embryo; three brain  vesicles are clearly visible to the left. 
Five well-formed somites (s) plus the presomitic segmental plate (sp) are shown in B, C, and D. The last two somites show no cytotactin. Note 
also the low level ofcytotactin staining in the ectoderm (e) compared with fibronectin (C) and laminin (D). Bar, 50 um in A; 100 um in B-D. 
cells from the neural tube (Fig. 4, A-D). In the cephalic region 
of a  6-somite embryo (Fig. 4, A and B), staining is punetate 
in the presumptive neural crest area, similar to the distribution 
of cytotactin at gastrulation as middle layer cells delaminate 
from the epiblast (Fig.  1 C). At the  12-somite stage (Fig. 4, C 
and D), the mass of crest cells is completely surrounded by 
cytotactin before crest cell migration. At this stage, a compar- 
ison of cytotactin distribution (Fig. 4, E, G, and/) with that 
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together in the areas where crest cells will soon migrate, which 
includes  the  head  region  (Fig.  4,  E  and  F),  neural  tube, 
notochord, and somites (Fig. 4, G-J). In contrast, cytotactin 
is not seen in regions where crest cells will not migrate, such 
as lateral plate mesoderm and ectoderm of the trunk (Fig. 
4/), although in all of these areas fibronectin is prominent 
(Fig.  4J).  The accumulated data indicate that cytotactin is 
clearly distinct in location from other ECM molecules such 
as laminin and fibronectin and that cytotactin is expressed in 
a  pattern that is more specifically restricted to early neural 
crest pathways than either fibronectin or laminin. 
The overall distribution  pattern of cytotactin at different 
stages in  the early embryo is schematically summarized in 
Fig.  5.  At  gastrulation,  cytotactin  appears throughout  the 
basement membrane in the anterior regions of the embryo 
where  gastrulation  is  complete (Fig.  5A).  This  differential 
anterior-posterior expression  of the  molecule is  seen again 
during neurulation where formation of both the neural plate 
and  the  notochord  precedes cytotactin deposition  in  their 
basement membranes (Fig.  5 B); this pattern repeats itself in 
the  formation of somites (Fig.  5,  B  and  C).  In  addition, 
cytotactin appears in the head mesenchyme, within the aorta, 
in  the  endocardium  of the  early  heart,  and  in  the  early 
sclerotome. The molecule is not present in the myocardium 
or  dermamyotome.  The  early  distribution  patterns  fore- 
shadow later appearances in the nervous system, developing 
cartilage, smooth muscle, and basement membranes of  several 
tissues,  and emphasize the restricted and sometimes transient 
distribution among certain tissues. The restricted tissue distri- 
bution of cytotactin, its order of appearance, and its preva- 
lence in the nervous system suggest that it may function in a 
highly specialized fashion as compared with  fibronectin or 
laminin. 
Cytotactin  Expression  in the Nervous System 
Cytotactin was initially isolated from embryonic brain tissue 
and was shown to be involved in glia-neuron interaction in 
in vitro assays (20).  It was found to be expressed by glia but 
not by neurons of the central nervous system (CNS). It was 
therefore especially important to examine the appearance of 
this molecule in  various regions of the nervous system. As 
discussed above, cytotactin is present in the basement mem- 
brane  of the  early  CNS  before its  differentiation  from an 
epithelial tube.  By 6-7 embryonic days,  cytotactin appears 
homogeneously, but at low levels in the spinal cord (Fig. 6A). 
During development, the level of cytotactin increases, and in 
the spinal cord does not appear to be preferentially expressed 
in particular areas such as white matter tracts that will become 
heavily myelinated (Fig. 6 B). Similarly, cytotactin appears in 
the brain at 6-7 embryonic days (Fig.  6 C) and is present in 
all areas of the brain during development. In the peripheral 
nervous system (PNS), cytotactin is associated with the early 
dorsal root ganglion as it forms between the neural tube and 
the dermamyotome (Fig. 6D). Staining is also prominent in 
cells within the more mature dorsal root ganglion (Fig. 6 E). 
In  the  developing  sciatic  nerve  (Fig.  6F),  cytotactin  is 
associated with  the  perineurium  of developing nerve,  and 
with  Schwann  cells  within  the  nerve.  The  molecule  also 
appears in developing cartilage of both the axial (Fig. 6A) and 
appendicular skeleton (Fig. 6F); in more mature cartilage, it 
remains only in the perichondrium (Fig.  6B). Cytotactin is 
absent  from the  developing skeletal  muscle  and  from the 
ectoderm of the limb bud (Fig.  6 F) throughout its develop- 
ment. 
During the development of the cerebellum, neurons of the 
external granule layer migrate to the internal granule layer 
using  radial  glial  cells  as  guides  (34).  Consistent  with  its 
appearance on glial cells, but not neurons of the CNS, cyto- 
tactin is present in this radial pathway, from the early devel- 
opment of the cerebellum (not shown). As shown previously 
(20),  cytotactin homogeneously stains the deeper cerebellar 
layers and remains associated with the radial glial fibers during 
migration of granule cells through the molecular layer. 
To determine whether there was another example of cyto- 
tactin expression associated with cell movement in the CNS, 
we  studied  in  detail  the  distribution  of cytotactin  during 
development of the retina. As the eye develops from the optic 
cup, cytotactin strongly stains the basement membrane sur- 
rounding both the lens and optic cup (presumptive retina) 
(Fig.  7D). By day 4, it is present at low levels on the optic 
fiber layer where axons are growing toward the optic nerve 
(Fig.  7E),  As  neurite  migration  begins  within  the  retina, 
forming its  complex laminar  structure  (E7),  the  molecule 
appears at low levels in a  radial pattern through the retina 
and  remains on  the  optic fiber layer (Fig.  7F).  By day 9, 
cytotactin staining is observed in both the inner and the newly 
developing outer plexiform layer, and radially at low levels 
between these layers (Fig. 7 G). By day 12, when ganglion cells 
have ceased their migration through the inner plexiform layer, 
radial staining is diminished while strong cytotactin staining 
remains in  the inner and outer plexiform layers (Fig.  7H). 
This pattern is stabilized by day 17 (Fig. 7/), although staining 
of the outer plexiform layer is somewhat decreased. The data 
on cytotactin distribution in the retina and cerebellum clearly 
indicate the occurrence of cytotactin on glial cells at sites of 
known cell migration. This takes on particular significance in 
Figure 4. Cytotactin appearance during formation of neural crest cells and comparison of cytotactin and fibronectin in early neural crest 
migratory pathways. (A and B) The presumptive neural crest cell area (pnc)  in the cephalic region of a 6-somite embryo shows punctate 
cytotactin staining as the neural tube (nt) fuses. B is the corresponding phase image. (C and D) In the trunk region of a twelve somite embryo, 
cytotactin surrounds the neural crest cells (nc) before their migration. D is the corresponding phase image. E-J are transverse sections at three 
axial levels stained with anti-cytotactin  antibodies (E, G, and/) or anti-fibronectin antibodies (F, H, and J). E and F are sections through the 
head and optic vesicles (or), arrows point to the ventricular surface of the optic vesicle; G and H are more posterior sections showing the 
pharynx ventral to the primordium of the heart (h); I and J are sections through a somite (s) showing the absence of cytotactin (/') in the lateral 
plate (lp), an area where fibronectin (J) is prominent. Bar, 50 #m in B and D; 100 tzm in F, H, and J. 
Crossin et al. Site-restricted  Expression of  Cytotactin  1923 Figure 5. Summary schematic  diagram indicating restricted cytotactin appearance in the early embryo. Stippled  areas represent  the distribution 
of cytotactin in (A) a bead process stage embryo, (B) a 10-somite  embryo (stage 10), and (C) a stage 18 (E3) embryo. Note the persistence  of 
differential  staining in anterior and posterior regions  through the first 3 d of  development. 
light of  observations that neuron-glia adhesion can be blocked 
by anti-cytotactin (20). 
Appearance of Cytotactin at Nonneural Sites 
We previously reported that cytotactin, although isolated from 
brain,  was  present  at  a  number of nonneural  sites  in  the 
embryo. We  have  now confirmed that  this  distribution  is 
general  for all  smooth  muscle,  lung  basement  membrane 
throughout its development, and kidney basement membrane 
from mid-developmental through adult stages. 
In the small intestine, cytotactin stains  only the smooth 
muscle layer (Fig.  8A),  while fibronectin is present at  low 
levels in both the smooth muscle layer and the submucosa 
(Fig.  8B).  Staining  of the large ganglionic plexuses in  the 
gizzard (Fig.  8,  C  and D) clearly indicates the presence of 
cytotactin (Fig.  8 C) both in the smooth muscle and within 
some cells of the plexuses (a further indication of its associa- 
tion with peripheral glia), in contrast to fibronectin (Fig. 8D), 
which  is  present  in  the  muscle  but  not  within  the  nerve 
plexuses.  Cytotactin is  also  associated  with  other types of 
smooth muscle. Arterial smooth muscles stain strongly (Fig. 
8 E), as shown above for the early development of the aorta. 
In the heart (Fig.  8F),  valvular material,  which is derived 
from the strongly cytotactin-positive endocardium (Fig.  2A 
and 4 G), continues to express high levels of the molecule in 
striking contrast to the cardiac muscle which completely lacks 
the protein. As the erector muscles of the feathers develop, 
they express large amounts ofcytotactin (Fig. 8 G). High levels 
are also  observed in  bronchial smooth  muscles (Fig.  8H). 
These results illustrate that cytotactin is associated both with 
smooth muscles and with peripheral glia of their associated 
nerves. Because smooth muscle cells are known to synthesize 
high amounts of cytotactin, these results suggest a functional 
role for the molecule in neuron-smooth muscle interaction. 
Cytotactin  is  a  prominent  component  of the  basement 
membrane of both the developing lung and  kidney but  it 
appears in a  different time sequence in each organ.  In  the 
lung, it is present when the initial lung buds form from the 
esophagus (20),  and is prominent in the bronchi and para- 
bronchi throughout their development (20; Fig.  8H). In the 
kidney, cytotactin is absent during the earliest stages of de- 
velopment, but appears surrounding the mesonephric tubules 
by  embryonic day  7  (Fig.  8/).  By  day  13,  it  is  strongly 
expressed as a component of both the tubular and glomerular 
basement membrane (Fig.  8//).  These results indicate that 
cytotactin is  an  important  component of basement  mem- 
branes; while present together with other ECM molecules, it 
is expressed at different times and in different sequences. 
Biochemical Properties of Cytotactin Expressed in 
Various Tissues 
Cytotactin polypeptides of Mr 220,000 and a closely spaced 
doublet of Mr 200,000 and Mr  190,000 were previously iso- 
lated from buffer and  Nonidet P-40 extracts of embryonic 
brain, and were found to be synthesized in culture by glial 
cells and by cells of 9-d embryonic gizzard, lung, and kidney 
(20).  However, in preliminary experiments using other em- 
bryonic and adult tissues including adult brain, little cytotac- 
tin was extracted under these conditions. Efficient extraction 
of cytotactin from embryonic and adult tissues was obtained 
at high pH (30 mM diethylamine, 1 mM EDTA, pH  11.5). 
To determine the biochemical nature of the cytotactin anti- 
gens in various tissues at different ages, we did immunoblots 
of high pH extracts of whole embryos or isolated embryonic 
and adult organs (Fig. 9). A characteristic pattern of  cytotactin 
polypeptides was  observed in  material extracted from El2 
brain, kidney, lung, and gizzard (Fig. 9, lanes 1-4). No cyto- 
tactin was observed in tissues that exhibited no immunohis- 
tochemical staining,  such as skeletal and heart muscle and 
liver (Fig. 9, lanes 5-7). Cytotactin was also extracted from 2- 
d  whole embryos (Fig.  9,  lane 8).  The same  polypeptides, 
including reproducible fragments of Mr 55,000 in brain and 
The Journal of CeU Biology, Volume  102, 1986  1924 Figure 6. Expression of cytotactin in the developing CNS and PNS. Transverse section through a 7-d embryonic trunk (A) shows low levels of 
cytotactin in the spinal cord, surrounding the notochord (n), and prominent staining in the developing cartilage (ct). By E 13 (B) cytotactin has 
increased in the spinal cord and has disappeared  from the maturing cartilage, remaining only in the surrounding  perichondrium  (pc). In the 
E7 optic lobe (C), cytotactin appears in all layers, most prominently on the developing stratum opticum (lower part of  photograph). (D and E) 
The developing (E3) dorsal root ganglion (D, delineated by arrows) contains low levels of cytotactin that persist in the ganglion at day 13 (E). 
(F) The developing sciatic nerve (n) of an E4 embryo shows cytotactin within the nerve and in the surrounding perineurium,  as well as in the 
developing cartilage (upper right). Cytotactin is absent from the limb ectoderm (e). Bar, 100/zm. 
Figure 7. Differential cytotactin distribution  in the retina. (A) In the E3 embryo, cytotactin is present in the basement  membrane of the lens 
(1) and the presumptive retina (pr). (B) Cytotactin appears at E4 in the optic fiber layer (off) when axons are migrating along this layer toward 
the optic nerve. (C) As neurite  migration begins within the retina itself (E7), cytotactin  appears in a radial pattern  through the retina while 
remaining on the off. (Intense staining at the bottom of the photograph  is in cartilage surrounding  the eye.) (D) By E9, cytotactin staining is 
observed in the inner (ipl) and at low levels on the outer (opl) plexiform layers, and the radial staining is diminished.  (E) Radial staining 
disappears by El2, after migration is completed but remains on both the ipl and at low levels on the opl through El7. Bars, 50 ~m. 
Mr 65,000 in lung and gizzard, were recognized by monoclo- 
nal antibodies to cytotactin. These results indicate that cyto- 
tactin  polypeptides are similar in all  embryonic tissues and 
that the observed staining patterns  reflect the expression of 
authentic cytotactin by these tissues in vivo. 
In high pH extracts of adult tissues, cytotactin polypeptides 
of Mr 200,000 and Mr 220,000 were present in brain, kidney, 
and lung (Fig. 9, lanes 9-11).  In the gizzard (Fig. 9, lane 12), 
the Mr 200,000 peptide was seen along with a major compo- 
nent of Mr 100,000. All of these forms of cytotactin were also 
recognized  by  a  monoclonal  antibody  that  recognizes  an 
antigenic determinant  retained in cytotactin molecules syn- 
thesized in the presence of tunicamycin (i.e.,  a non-carbohy- 
drate determinant). Although we previously detected in adult 
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Figure 8. Occurrence of cytotactin 
at extra-neural sites. (A and B) In 
the El2 small intestine, eytotactin 
(,4)  strongly  stains  the  smooth 
muscle layer (sm) compared with 
fibronectin (B), which stains both 
smooth muscle and mucosal (m) 
layers at low levels. The presence 
of small amounts of cytotactin in 
the enteric ganglia is more appar- 
ent in the gizzard (C) where strong 
smooth  muscle  staining  is  also 
seen.  Fibronectin (D)  stains giz- 
zard smooth muscle but not gan- 
glia.  (E)  Transverse  section 
through the anterior portion of  the 
heart (El3) shows eytotaetin stain- 
ing in the arterial smooth muscles 
as they exit the heart. (F) Sagittal 
sections through  the  heart  (El3) 
show  cytotactin  staining  only 
within the  endocardially derived 
valves but not in cardiac muscle. 
(G) Cytotactin strongly stains cells 
at the base of developing feather 
buds (El2), precursors to the erec- 
tor smooth muscles of the mature 
feather.  (H) Cytotactin is present 
in the El2 lung both in the base- 
ment membranes of the parabron- 
chi and in the smooth muscles of 
the larger bronchi. (I and J) Cyto- 
tactin first appears in the kidney 
tubule basement membrane at E7 
(I) and is expressed  at high levels 
in both the tubule and glomerular 
basement membranes by E 13 (J). 
Bar, 100 #m. brain lower molecular weight components, these components 
are now minor or absent (Fig. 9, lane 9) using the high pH 
extraction conditions and the cytotacain antibodies used in 
this study. It appears that the Mr 200,000 and 220,000 com- 
ponents are the major proteins recognized by both polyclonal 
and monoclonal anti-cytotactin antibodies in both embryonic 
and adult tissues. 
Cytotactin Distribution in the Adult 
To determine the relationship between cytotactin expression 
in embryonic and adult tissues,  we examined its histological 
distribution in several regions in the adult. The distribution 
of adult cytotactin was found to be similar in most respects 
(Fig.  10) to cytotactin distribution in embryonic tissues.  Cy- 
totactin is found in the forebrain (Fig.  10A) and molecular 
layer of  the cerebellum (Fig. 10B). Cytotactin is also expressed 
in the basement membrane of kidney and lung (Fig.  10, C 
and D), is prominent in both gut and arterial smooth muscles 
(Fig.  10, E and F), and is also seen in the smooth muscles of 
the feather (Fig.  10G).  The adult skin provides one striking 
difference in cytotactin expression: cytotactin appears in the 
epidermal basement membrane of the adult skin in contrast 
to the embryonic skin in which no cytotactin is found. 
Discussion 
We have described here the distribution of a new cell-associ- 
ated ECM molecule, cytotactin, during development of the 
chicken. The molecule is found during early embryogenesis 
in  a  more  restricted pattern  than  that  reported for ECM 
proteins such as fibronectin and laminin. It is present at a 
number of nonneural sites and, unlike laminin and fibronec- 
tin,  appears  during  histogenesis  of the  nervous system  in 
association with giia. Cytotactin is present in adult tissues in 
locations  concordant  with  those  in  which  it  is  found  in 
embryonic tissues.  The combined observations suggest that 
cytotactin appears in four major areas of critical morphoge- 
netic and histogenetic activity in embryonic tissue: (a) at sites 
of major morphological changes during early embryogenesis, 
especially in association with cell movement; (b) in glial cells 
of the CNS and PNS; (c) in basement membranes of a variety 
of tissues  in a  temporal sequence distinct from other ECM 
proteins; and (d) in smooth muscles. 
lmmunofluorescent staining for cytotactin indicated that 
this cell-associated protein appears at the time of gastrulation 
in the basement membrane separating the epiblast from the 
underlying mesoderm. The molecule also appears at the level 
of the primitive streak in a punctate pattern that reflects the 
breakdown of  the basement membrane as cells ingress to form 
the middle layer. At neurulation, cytotactin appears in the 
basement  membrane  of the  neural  tube,  notochord,  and 
somites  in  a  striking  pattern  that  appears  earliest  in  the 
anterior, most mature portion of the embryo. Furthermore, 
this  staining  pattern  delineates  the  early  neural  crest  cell 
migratory pathways. When neural crest cells delaminate from 
the neural tube, the mass of  cells is surrounded by cytotactin; 
their subsequent migratory pathways are lined by cytotactin. 
Although a  similar distribution is  observed for fibronectin, 
fibronectin also appears in widespread areas where crest cells 
do not migrate, such as the lateral plate mesoderm and lateral 
ectoderm, both of which lack cytotactin. These results raise 
Figure 9. Immunobtots of cytotactin polypeptides  in various embry- 
onic and adult tissues. Extracts of various E 12 and adult tissues and 
E2 embryos  were prepared as described  in the Materials  and Methods, 
were resolved on 7.5% (lanes 1-8) or 6% (lanes 9-12) SDS polyac- 
rylamide gels, and were immunoblotted with rabbit anti-cytotactin. 
Lanes 1-7, El2 extracts: lane I, brain; 2, kidney; 3, lung; 4, gizzard; 
5, heart; 6, skeletal muscle; 7, liver; 8, whole 2-d embryo dissected 
free of extra-ernbryonie  membranes. Lanes 9-12, adult extracts;  lane 
9, brain; 10, kidney; 11, lung; 12, g~zzard. 
the possibility that cytotactin, perhaps in  conjunction with 
fibronectin (44),  its receptor or other associated molecules 
such as the proteoglycan that co-purifies with cytotactin (20), 
directs or modulates cell migration in these areas. Moreover, 
cytotactin is found in several areas of active cell migration, 
both  in  the  early embryo and  in  the  CNS,  including  the 
sclerotomal cells of  the dispersing somite, in the endocardium 
of the heart, in the cerebellum, and retina. 
Cytotactin is synthesized by glia  but not neurons of the 
CNS (20) or PNS (unpublished observations). Immunolocal- 
ization data strongly support this observation and suggest that 
cytotactin may serve as an early marker of glial cell differen- 
tiation. Cytotactin is present in all regions of the brain and 
spinal cord, first appearing at approximately embryonic day 
6 to 7. This timing and distribution pattern is consistent with 
times of large increases in the number of  glial cells in the CNS 
(1). In addition, cytotactin staining occurs in a radial pattern 
in  both  the  retina  and  cerebellum, where  cell  migrations 
occur,  further correlating its  appearance with  sites  of cell 
movement, and suggesting that the radial glia which provide 
a guide for neuronal migration in the cerebellum also express 
cytotactin. In the PNS, cytotactin both surrounds the periph- 
eral nerves, as do laminin and fibronectin, and it is found 
within the  nerves,  suggesting  its association with Schwann 
cells. Although both laminin and fibronectin strongly support 
neurite outgrowth, neither has been definitively found in the 
CNS. For this reason, cytotactin may have special significance 
in the CNS in vivo in supporting neuronal migration on glia. 
Moreover, a relationship between cytotactin expression and 
cell  migration  in  both  the  CNS  and  PNS  is  likely to  be 
particularly important. In a  preliminary study, we have ob- 
served that  both  polyclonal and  monoclonal antibodies to 
cytotactin inhibit cell migration in cerebellar slices in vitro 
(Chuong, C.-M., and G. M. Edelman, unpublished observa- 
tions).  A  murine  molecule  called  J l  glycoprotein having 
biochemical properties similar to cytotactin has recently been 
reported (26)  to mediate neuron-astrocyte adhesion and to 
be  expressed  by  astrocytes and  oligodendrocytes but  was 
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Figure  10.  Distribution of cyto- 
tactin in the adult. Cytotactin ap- 
pears in adult tissues in patterns 
similar to its distribution in em- 
bryonic  tissues.  Cytotactin  is 
present in the adult forebrain (A), 
molecular layer  of the  cerebel- 
lum (B), kidney (C) and lung (D) 
basement  membranes,  and  giz- 
zard (E) and arterial (F) smooth 
muscle. In the adult skin (G-J), 
anti-cytotactin stains the erector 
smooth muscles (sin) and cells of 
the feather sheath 0~) below the 
rachis (r)  or central part  of the 
feather where the  feather barbs 
(b) insert. In contract to the em- 
bryo,  anti-cytotactin  labels  the 
basement membrane of the skin 
ectoderm (e) of the adult (I and 
J). H and Jare the corresponding 
phase images of G and L respec- 
tively. Bar, 100 um. A  B  C  D 
Figure 11. Fate maps comparing the distributions of CAMs, cytotactin, and fibronectin. (A) The presumptive areas of the blastoderm that will 
give rise to the different tissues has been established by various marking techniques (for review, see Vakaet, [48]). (B) The distributions of the 
three known CAMs (N-CAM  [.], L-CAM [/], and Ng-CAM [+]) are superimposed  upon the classical fate map. Note that N-CAM- and L- 
CAM-containing tissues map to distinct and contiguous regions within the blastoderm and that Ng-CAM, a secondary CAM, appears later and 
only within neuroectodermal  derivatives. (C and D) The distribution  of tissues expressing cytotactin (C, [-]) and fibronectin (D, [']) mapped 
onto the blastoderm.  Compare the widespread occurrence of cellular fibronectin  in most tissues, exclusive of the neuroectoderm,  with the 
restricted distribution  of cytotactin which is present in neuroectoderm  and notochord,  smooth muscle, urogenital system, in certain somite 
derivatives (sclerotome), and at low levels and at restricted times in ectoderm and endoderm.  The vertical bar represents the primitive streak 
(PS); Ec, intraembryonic and extraembryonic ectoderm; En, endoderm; H, heart; LP, lateral plate (splanchno- and somatopleurai mesoderm); 
N, nervous system; No, prechordal and chordamesoderm;  S, somite. 
described  only  in  the  nervous  system  as  a  cell  adhesion 
molecule specific to that system. Cytotactin is also involved 
in glia-neuron interactions and is synthesized at high levels 
by CNS glia,  but  in  addition  occurs in  the  PNS  and  at  a 
number of extra-neural  sites.  If J 1 is  in  fact evolutionarily 
related  to  cytotactin,  it  is  likely  to  be  found with  similar 
distributions to cytotactin both in the nervous system and at 
extra-neural sites.  If this turns out to be the case, J 1 would be 
more accurately designated as an ECM protein rather than a 
CAM. 
The  expression  of cytotactin in  several  nonneural  areas, 
together with its known function in glia-neuron interactions, 
raise  the  possibility that,  although  it  is an  ECM  molecule, 
cytotactin may nonetheless mediate cell-cell adhesion in cer- 
tain situations. A particularly interesting case is that of  smooth 
muscle.  It is known that smooth muscle precursors express 
N-CAM, but that it is lost before differentiation into mature 
smooth muscle cells.  Thus, the cytotactin that remains after 
the disappearance of N-CAM may be involved both in adhe- 
sion between mature smooth muscle cells and in interactions 
of neurons with smooth muscle. The appearance of cytotactin 
in basement membranes of the kidney and lung may help to 
stabilize the tubular epithelia as do other ECM proteins, but 
because  of the  temporal  differences  in  the  appearance  of 
cytotactin and other ECM molecules (especially in the kid- 
ney), it  may also  stabilize  interactions  among differing cell 
types necessary for tissue function. 
The accumulated data allow us to construct a  composite 
fate  map as referred  back onto the  avian  blastoderm  (Fig. 
11A), providing a useful summary for comparing the different 
tissue  expression  of cytotactin (Fig.  11 C),  the  CAMs (Fig. 
11 B), and fibronectin (Fig.  11 D). In the fate map of embry- 
onic tissues, cytotactin expression is restricted to the neuroec- 
toderm and only certain mesodermal and endodermal tissues, 
although the early ectoderm expresses cytotactin transiently. 
Thus, cytotactin, like the CAMs and fibronectin, is expressed 
by cells from all three germ layers but in a pattern restricted 
to only certain  tissues  and  at certain  times  according to a 
schedule different from other ECM molecules such as fibro- 
nectin and laminin.  The fate map of cytotactin distribution 
completely includes the map region of Ng-CAM and overlaps 
with many regions of N-CAM expression; in contrast, fibro- 
nectin and laminin are largely absent from CNS tissue.  Al- 
though cytotactin is involved in glia-neuron interactions  it 
does  not  appear  to  be  the  glial  ligand  for Ng-CAM  (20). 
However, it remains possible that cytotactin may interact with 
N-CAM or Ng-CAM and in this way affect glia-neuron or 
other cellular interactions indirectly. Other potential cellular 
receptors for cytotactin in the brain and other tissues remain 
to be explored. 
The expression of both CAMs and SAMs (such as cytotac- 
tin) in a spatially and temporally regulated fashion could help 
govern cellular interactions and movements during embryo- 
genesis (11). While the CAMs are considered to be morpho- 
regulatory proteins because they mediate  cell adhesion and 
are  expressed  before  morphological  changes,  cytotactin  is 
expressed in areas of  cell movement and subsequent to several 
major morphogenetic events such as neural tube  formation 
and epithelialization  of the somites. Thus, expression of cy- 
totactin may stabilize previously formed structures as well as 
provide a  new environment for cellular interactions or cell 
movement leading to further morphological processes.  The 
distribution pattern of cytotactin indicates that map-restricted 
ECM  molecules exist  and  raises  the  possibility that  others 
may be found. Coordinated developmental regulation of gene 
expression of both CAMs and SAMs may be critical events 
leading to morphogenesis. 
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